Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 1
2002 1
2003 4
2004 1
2006 1
2007 8
2008 4
2009 4
2010 4
2011 4
2012 3
2013 8
2014 5
2015 2
2016 6
2017 3
2019 3
2020 4
2021 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females.
Shi LW, Li J, Yu BW, Huang LR, Li K, Ji M, Zhou LY, Yuan L, Yang SY, Chen JJ, Wang L, Jiang ZW, Li RC, Li YP, Xia JL, Mo ZJ, Li CG. Shi LW, et al. Among authors: li rc. Hum Vaccin Immunother. 2023 Dec 31;19(1):2209001. doi: 10.1080/21645515.2023.2209001. Epub 2023 May 30. Hum Vaccin Immunother. 2023. PMID: 37249310 Free PMC article. Clinical Trial.
Safety and immunogenicity of a pichia pastoris-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine in healthy Chinese women aged 9-45 years: A randomized, double-blind, placebo-controlled phase 1 clinical trial.
Li J, Shi LW, Yu BW, Huang LR, Zhou LY, Shi L, Jiang ZW, Xia JL, Wang XY, Li RC, Yuan L, Li YP, Li CG. Li J, et al. Among authors: li rc. Vaccine. 2023 May 5;41(19):3141-3149. doi: 10.1016/j.vaccine.2023.04.009. Epub 2023 Apr 13. Vaccine. 2023. PMID: 37061370 Free article. Clinical Trial.
Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.
Yu XJ, Li J, Lin ZJ, Zhao H, Lin BZ, Qiao YL, Hu YM, Wei LH, Li RC, Huang WD, Wu T, Huang SJ, Li CG, Pan HR, Zhang J. Yu XJ, et al. Among authors: li rc. Hum Vaccin Immunother. 2020 Jul 2;16(7):1630-1635. doi: 10.1080/21645515.2020.1761202. Epub 2020 Jun 16. Hum Vaccin Immunother. 2020. PMID: 32544361 Free PMC article. Clinical Trial.
Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial.
Su YY, Lin BZ, Zhao H, Li J, Lin ZJ, Qiao YL, Wei LH, Hu YM, Li RC, Zhuang SJ, Sun G, Zheng ZZ, Huang SJ, Wu T, Zhang J, Pan HR, Li CG. Su YY, et al. Among authors: li rc. Hum Vaccin Immunother. 2020 Jul 2;16(7):1636-1644. doi: 10.1080/21645515.2019.1691413. Epub 2019 Nov 26. Hum Vaccin Immunother. 2020. PMID: 31770068 Free PMC article. Clinical Trial.
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ, Pan QJ, Zhang X, Li Q, Hong Y, Zhao C, Zhang WH, Li YP, Chu K, Li M, Jiang YF, Li J, Zhao H, Lin ZJ, Cui XL, Liu WY, Li CH, Guo DP, Ke LD, Wu X, Tang J, Gao GQ, Li BY, Zhao B, Zheng FX, Dai CH, Guo M, Zhao J, Su YY, Wang JZ, Zhu FC, Li SW, Pan HR, Li YM, Zhang J, Xia NS. Qiao YL, et al. Among authors: li rc. J Natl Cancer Inst. 2020 Feb 1;112(2):145-153. doi: 10.1093/jnci/djz074. J Natl Cancer Inst. 2020. PMID: 31086947 Free PMC article. Clinical Trial.
65 results